1[1]Woolf CJ,Chong MS.Preemptive analgesia treating postoperative pain by preventing the establishment of central sensitization.Anesth Analg,1993,77(2):362-369.
2[2]Moote C.Efficacy of nonsteroidal anti-inflammatory drugs in the management of postoperative pain.Drugs,1992,44(suppl 5):14-29.
3[3]Kehlet H.Multimodal approach to control postoperative pathophysiology and rehabilitation.Br J of Anesthesia,1997,78(5):606-617.
2Pruss TP,Stroissnig H,Radhofer-Welte S, et al. Overview of the pharmacological properties, pharmacokinetics and animal safety assessment of lornoxicam. Postgrad Med J,1990,66(Suppl 4) :S18-21.
3Olkkola KT,Brunetto AV, Mattila MJ. Pharmacokinetics of oxicam nonsteroidal anti-inflammatory agents. Clin pharmacokinet, 1994,26:107-120.
4Hitzenberger G,Radhofer-Welte S, Takacs F, et al. Pharmacokinetics of lornoxicam in man. Postgrad Med J,1990,66(Suppl 4) :S22-27.
5Kullich W,Klein G. Influence of the nonsteroidal anti-inflammatory drug lornoxicam iv on the secretion of the endogenous opiate peptides dynorphin and endorphin. Aktuel Rheumatol, 1992,17:128-132.
6Norholt SE,Sindet-Pedersen S,Larsen U,et al. Pain control after dental surgery: a double-blind, randomised trial of lornoxicam versus morphine. Pain, 1996,67: 335-343.
